The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
The growing burden of antimicrobial resistance
Abstract
Since the first usage of antimicrobials, the burden of resistance among bacteria has progressively increased and has accelerated within the last 10 years. Antibiotic resistance genes were present at very low levels prior to the introduction of antibiotics and it is largely the selective pressure of antibiotic use and the resulting exposure of bacteria, not only in humans but also in companion and food animals and the environment, which has caused the rise. The increasing mobility across the globe of people, food and animals is another factor. Examples of this are the international pandemic of different genotypes of CTX-M extended-spectrum beta-lactamases (particularly CTX-M-14 and -15) and the emergence of the carbapenemase KPC-1 in both the USA and Israel. This review details examples of both the emergence and dissemination through different genetic routes, both direct and indirect selective pressure, of significance resistance in Staphylococcus aureus, Enterococcus species, Enterobacteriaceae and Pseudomonas/Acinetobacter. The response made by society to reduce resistance involves surveillance, reduced usage, improved infection control and the introduction of new antimicrobial agents. Although efforts are being made in all these areas, there is an urgent need to increase the effectiveness of these interventions or some bacterial infections will become difficult if not impossible to treat reliably.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231 · cited 1×
“Resistance to carbapenems can occur through a range of mechanisms, which include the loss of specific porins and the expression of efflux pumps, for which the mex A/B and X/Y systems are very important.(62) A worrying survey from Canada—a country generally considered to have low levels of antibiotic resistance— of all…”
BackgroundThe CTX-M β-lactamase pandemic
Cantón, R., & Coque, T. M. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.011 · Cited by 1,147
Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat
Grundmann, H., Aires-de-Sousa, M., Boyce, J., & Tiemersma, E. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68853-3 · Cited by 1,101
The worldwide emergence of plasmid-mediated quinolone resistance
Robicsek, A., Jacoby, G. A., & Hooper, D. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70599-0 · Cited by 966
Plasmid-Determined AmpC-Type β-Lactamases
Philippon, A., Arlet, G., & Jacoby, G. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.1-11.2002 · Cited by 816
Prevalence in the United States of aac(6 ′ ) - Ib - cr Encoding a Ciprofloxacin-Modifying Enzyme
Park, C. H., Robicsek, A., Jacoby, G. A., Sahm, D., & Hooper, D. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00915-06 · Cited by 757
Staphylococcus aureus Panton-Valentine Leukocidin Causes Necrotizing Pneumonia
Labandeira-Rey, M., Couzon, F., Boisset, S., Brown, E. L., Bes, M., Benito, Y., Barbu, E. M., Vazquez, V., Höök, M., Etienne, J., et al. (2007) · Science · doi:10.1126/science.1137165 · Cited by 709
More extended-spectrum beta-lactamases
Jacoby, G. A., & Medeiros, A. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1697 · Cited by 700
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam Antibiotics
Medeiros, A. A. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s19 · Cited by 587
Voyich, J. M., Otto, M., Mathema, B., Braughton, K. R., Whitney, A. R., Welty, D., Long, R. D., Dorward, D. W., Gardner, D. J., Lina, G., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/509506 · Cited by 565
Lee, J. H. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.11.6489-6494.2003 · Cited by 513
The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter
Livermore, D. M., & Woodford, N. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.07.008 · Cited by 510
Morris, J. G., Shay, D. K., Hebden, J. N., McCarter, R. J., Perdue, B. E., Jarvis, W., Johnson, J. A., Dowling, T. C., Polish, L. B., & Schwalbe, R. S. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-4-199508150-00002 · Cited by 489
Methicillin-resistant Staphylococcus aureus ST398 in Humans and Animals, Central Europe
Witte, W., Strommenger, B., Stanek, C., & Cuny, C. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1302.060924 · Cited by 386
The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus
Appelbaum, P. C. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01344.x · Cited by 376
Ayliffe, P. G. A. J., Buckles, M. A., Casewell, M. W., Cookson, B. D., Cox, R. A., Duckworth, G. J., French, G. L., Griffiths-Jones, M. A., Heathcock, R., Humphreys, H., et al. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90293-6 · Cited by 370
Karim, A., Poirel, L., Nagarajan, S., & Nordmann, P. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10762.x · Cited by 359
Damier-Piolle, L., Magnet, S., Brémont, S., Lambert, T., & Courvalin, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00732-07 · Cited by 357
High-level vancomycin-resistant enterococci causing hospital infections
Uttley, A. H. C., George, R. C., Naidoo, J., Woodford, N., Johnson, A. P., Collins, C. H., Morrison, D., Gilfillan, A. J., Fitch, L. E., & Heptonstall, J. (1989) · Epidemiology and Infection · doi:10.1017/s0950268800030478 · Cited by 343
Tiwari, H. K., & Sen, M. R. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-156 · Cited by 335
Waldron, D. E., & Lindsay, J. A. (2006) · Journal of Bacteriology · doi:10.1128/jb.00418-06 · Cited by 300
Loeffler, A., Boag, A. K., Sung, J., Lindsay, J. A., Guardabassi, L., Dalsgaard, A., Smith, H., Stevens, K. B., & Lloyd, D. H. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki312 · Cited by 300
Prevalence and clonality of extended-spectrum β-lactamases in Asia
Hawkey, P. M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01855.x · Cited by 289
Self-citationRodriguez-Bano, J., Navarro, M. D., Romero, L., Muniain, M. A., Cueto, M. D., Rios, M. J., Hernandez, J. R., & Pascual, A. (2006) · Clinical Infectious Diseases · doi:10.1086/508877 · Cited by 279
CTX-M: changing the face of ESBLs in the UK
Livermore, D. M., & Hawkey, P. M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki239 · Cited by 278
Self-citationHsueh, P.-R., Chen, W.-H., & Luh, K.-T. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.08.016 · Cited by 262
Leavitt, A., Navon-Venezia, S., Chmelnitsky, I., Schwaber, M. J., & Carmeli, Y. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00299-07 · Cited by 256
(1991) · FEMS Microbiology Letters · doi:10.1016/0378-1097(91)90112-n · Cited by 252
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
Peleg, A. Y., Potoski, B. A., Rea, R., Adams, J., Sethi, J., Capitano, B., Husain, S., Kwak, E. J., Bhat, S. V., & Paterson, D. L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl441 · Cited by 248
Production of l-DOPA by Aspergillus terreus
Chattopadhyay, S., & Das, A. (1990) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1990.tb03888.x · Cited by 243
Ruzin, A., Keeney, D., & Bradford, P. A. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm058 · Cited by 238
Sahm, D. F., Marsilio, M. K., & Piazza, G. (1999) · Clinical Infectious Diseases · doi:10.1086/520195 · Cited by 213
Chanawong, A., M'Zali, F. H., Heritage, J., Xiong, J.-H., & Hawkey, P. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.630-637.2002 · Cited by 211
Self-citationOverview of the Epidemiological Profileand Laboratory Detection of Extended-Spectrum β-Lactamases
Pfaller, M. A., & Segreti, J. (2006) · Clinical Infectious Diseases · doi:10.1086/500662 · Cited by 203
Ruzin, A., Visalli, M. A., Keeney, D., & Bradford, P. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1017-1022.2005 · Cited by 203
Community-acquired methicillin-resistant Staphylococcus aureus infections
Maltezou, H. C., & Giamarellou, H. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.11.004 · Cited by 197
Coelho, J. M., Turton, J. F., Kaufmann, M. E., Glover, J., Woodford, N., Warner, M., Palepou, M.-F., Pike, R., Pitt, T. L., Patel, B. C., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00699-06 · Cited by 191
Reinert, R. R., Low, D. E., Rossi, F., Zhang, X., Wattal, C., & Dowzicky, M. J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm310 · Cited by 189
Bager, F., Aarestrup, F. M., Madsen, M., & Wegener, H. C. (1999) · Microbial Drug Resistance · doi:10.1089/mdr.1999.5.53 · Cited by 164
Lautenbach, E., Weiner, M., Nachamkin, I., Bilker, W., Sheridan, A., & Fishman, N. (2006) · Infection Control & Hospital Epidemiology · doi:10.1086/507274 · Cited by 159
Hong, H., Hutchings, M. I., Neu, J. M., Wright, G. D., Paget, M. S. B., & Buttner, M. J. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04032.x · Cited by 145
Ensor, V. M., Shahid, M., Evans, J. T., & Hawkey, P. M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl422 · Cited by 143
Self-citationTan, C.-H., Li, J., & Nation, R. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01571-06 · Cited by 138
Mishaan, A. M. A., Mason, E. O., Martínez‐Aguilar, G., Hammerman, W. A., Propst, J. J., Lupski, J. R., Stankiewicz, P., Kaplan, S. L., & Hultén, K. G. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000151107.29132.70 · Cited by 134
The emergence and implications of metallo-β-lactamases in Gram-negative bacteria
Walsh, T. R. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01264.x · Cited by 131
Moland, E. S., Hanson, N. D., Black, J. A., Hossain, A., Song, W., & Thomson, K. S. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00756-06 · Cited by 126
Warren, R. E., Ensor, V. M., O'Neill, P., Butler, V. T., Taylor, J., Nye, K., Harvey, M., Livermore, D. M., Woodford, N., & Hawkey, P. M. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm517 · Cited by 124
Self-citationBratu, S., Brooks, S., Burney, S. N., Kochar, S., Gupta, J., Landman, D., & Quale, J. M. (2007) · Clinical Infectious Diseases · doi:10.1086/512370 · Cited by 122
Datta, N. (1969) · BMJ · doi:10.1136/bmj.2.5654.407 · Cited by 114
Keeney, D. R., Ruzin, A. V., & Bradford, P. A. (2007) · Microbial Drug Resistance · doi:10.1089/mdr.2006.9990 · Cited by 111
Aminoglycoside resistance in gram-negative bacilli during increased amikacin use
Gerding, D. N., & Larson, T. A. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90184-6 · Cited by 99
A Polyclonal Outbreak of Predominantly VanB Vancomycin-Resistant Enterococci in Northeast Ohio
Salata, R. A., Gordon, S., & Whalen, C. C. (1999) · Clinical Infectious Diseases · doi:10.1086/598636 · Cited by 78
Pitout, J. D. D., Chow, B. L., Gregson, D. B., Laupland, K. B., Elsayed, S., & Church, D. L. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01694-06 · Cited by 78
Ling, T. K. �., Xiong, J., Yu, Y., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.374-378.2006 · Cited by 77
Donskey, C. J., Hanrahan, J., Hutton, R. A., & Rice, L. B. (2000) · The Journal of Infectious Diseases · doi:10.1086/315428 · Cited by 76
Dobbs, T. E., Patel, M., Waites, K. B., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00850-06 · Cited by 71
Staphylococcus aureus Strains That are Hypersusceptible to Resistance Gene Transfer from Enterococci
Sung, J. M.-L., & Lindsay, J. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01442-06 · Cited by 61
Glycopeptide ResistancevanAOperons inPaenibacillusStrains Isolated from Soil
Guardabassi, L., Périchon, B., van HEIJENOORT, J., Blanot, D., & Courvalin, P. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4227-4233.2005 · Cited by 60
Tigecycline: in-vitro performance as a predictor of clinical efficacy
Hawkey, P. M., & Finch, R. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01621.x · Cited by 58
Self-citationBeltrametti, F., Consolandi, A., Carrano, L., Bagatin, F., Rossi, R., Leoni, L., Zennaro, E., Selva, E., & Marinelli, F. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01071-06 · Cited by 42
Antibiotic Resistance in the Environment, with Particular Reference to MRSA
Gaze, W. H., O’Neill, C., Wellington, E. M. H., & Hawkey, P. M. (2008) · Advances in applied microbiology · doi:10.1016/s0065-2164(07)00007-x · Cited by 40
Self-citationManagement of the Behavioral Manifestations of Dementia
Yeager, B. F., Farnett, L. E., & Ruzicka, S. A. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430030036004 · Cited by 38
Livermore, D. M., Reynolds, R., Stephens, P. J., Duckworth, G. J., Felmingham, D., Johnson, A. P., Murchan, S., Murphy, O. M., Gungabissoon, U., Waight, P., et al. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.05.025 · Cited by 24
Denys, G. A., Koch, K. M., & Dowzicky, M. J. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.11.004 · Cited by 17
Cited by
The re-emergence of natural products for drug discovery in the genomics era
Harvey, A. L., Edrada-Ebel, R., & Quinn, R. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4510 · Cited by 2,572
Azam, A., Ahmed, Oves, Khan, Habib, & Memic, A. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s35347 · Cited by 1,467
The negative impact of antibiotic resistance
Friedman, N. D., Temkin, E., & Carmeli, Y. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.12.002 · Cited by 870
Chemical use in salmon aquaculture: A review of current practices and possible environmental effects
Burridge, L., Weis, J. S., Cabello, F., Pizarro, J., & Bostick, K. (2010) · Aquaculture · doi:10.1016/j.aquaculture.2010.05.020 · Cited by 842
Sequencing-based methods and resources to study antimicrobial resistance
Boolchandani, M., D’Souza, A. W., & Dantas, G. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0108-4 · Cited by 522
Metadata
- Authors
- Hawkey, P. M.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-09-01
- Volume
- 62
- Issue
- Supplement 1
- Pages
- i1-i9
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2155448001
- Cited by
- 377
- References
- 66
- FWCI
- 9.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.